Publications

5803 Results

Cracking the resistance code: The molecular reclassification of cancer and precision therapy strategies

Authors
Nikanjam M
Journal / Conference
Semin Cancer Biol. 2025 Dec;117:57-68. doi: 10.1016/j.semcancer.2025.10.004. Epub 2025 Oct 30.NIHMS2120810
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID41175949
PMC
PMC12673920

Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection

Authors
Nishizaki D
Journal / Conference
NPJ Precis Oncol. 2025 Jul 24;9(1):253. doi: 10.1038/s41698-025-01038-w
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40707733
PMC
PMC12290096

Pan-Cancer Landscape of B- and T-Lymphocyte Attenuator: Implications for Potential Immunotherapy Combinations

Authors
Nishizaki D
Journal / Conference
JCO Precis Oncol. 2025 Aug;9:e2500304. doi: 10.1200/PO-25-00304. Epub 2025 Aug 6.NIHMS2093486
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40768679
PMC
PMC12331147

Personalized N-of-1 Combination Therapies for Advanced Gastrointestinal Stromal Tumors

Authors
Noh S
Journal / Conference
JCO Precis Oncol. 2025 Jul;9:e2500066. doi: 10.1200/PO-25-00066. Epub 2025 Jul 23.NIHMS2092363
Year
2025
Research Committee(s)
Gastrointestinal
PMID
PMID40700673
PMC
PMC12313172

On the use of external controls in clinical trials

Authors
Nuño MM
Journal / Conference
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):30-34. doi: 10.1093/jncimonographs/lgae046
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID39989040
PMC
PMC11848027

The importance of patient-centered research in oncology clinical trials: motivation for the Monograph series

Authors
Pugh SL
Journal / Conference
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):1-2. doi: 10.1093/jncimonographs/lgae052
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID39989042
PMC
PMC11848026

Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163

Authors
Saba NF
Journal / Conference
Clin Cancer Res. 2025 Jun 13;31(12):2339-2346. doi: 10.1158/1078-0432.CCR-24-4085.NIHMS2075936
Year
2025
PMID
PMID40227186
PMC
PMC12165817

Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912

Authors
Shanafelt TD
Journal / Conference
Blood Adv. 2025 Jan 14;9(1):224-228. doi: 10.1182/bloodadvances.2024013474
Year
2025
Research Committee(s)
Leukemia
PMID
PMID39163612
PMC
PMC11788128
Study Number(s)
CTSU/E1912

Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma

Authors
Tarhini AA
Journal / Conference
Clin Cancer Res. 2025 Aug 1;31(15):3249-3258. doi: 10.1158/1078-0432.CCR-24-3980. NIHMS2085262
Year
2025
Research Committee(s)
Melanoma
PMID
PMID40392969
PMC
PMC12316551
Study Number(s)
CTSU/E1609

CD40 transcriptomic expression patterns across malignancies: implications for clinical trials of CD40 agonists

Authors
Uehara Y
Journal / Conference
Cancer Immunol Immunother. 2025 Nov 3;74(12):359. doi: 10.1007/s00262-025-04197-8
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID41182434
PMC
PMC12583269